Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 8Genitourinary 6Breast 6Thoracic 5Gynecologic 5Gastrointestinal 5Tumor-Agnostic 4Plasma cell 4Other hematologic neoplasm 4Sarcoma 2Head & Neck 2Other solid neoplasm 1Myeloid 1

Conditions

Head and Neck Neoplasms 2Neoplasms 1Frailty 1

Interventions

Cisplatin 416Radiotherapy 240Radiotherapy, Intensity-Modulated 178Cetuximab 177Docetaxel 166pembrolizumab 148Carboplatin 121Fluorouracil 113Paclitaxel 90Nivolumab 82Gemcitabine 82Radiation 72Surveys and Questionnaires 71Drug Therapy 70toripalimab 68Surgical Procedures, Operative 64Magnetic Resonance Spectroscopy 63Capecitabine 50Blood Specimen Collection 50Chemoradiotherapy 46Biopsy 44camrelizumab 41durvalumab 40Radiosurgery 40Standard of Care 38Erlotinib Hydrochloride 34nimotuzumab 32130-nm albumin-bound paclitaxel 32tislelizumab 31apatinib 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Geriatric Assessment × Head & Neck × Clear all
NCT06638216 2025-08-28

PRE-KOVERI

Charite University, Berlin, Germany

Phase NA Completed
99 enrolled
Head & Neck

Frailty, Head and Neck Neoplasms

NCT01688323 2017-09-12

Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck Cancer

UNC Lineberger Comprehensive Cancer Center

Completed
3 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡